|Day Low/High||152.30 / 154.10|
|52 Wk Low/High||85.56 / 124.69|
ICU Medical will pay $900 million for the infusion therapy unit rather than $1 billion.
The health care sector has been a miserable performer lately -- but these five health trades are bucking the trend.
Diana is the first and only system to combine automated compounding and IV workflow technologies with remote pharmacist notification to help minimize errors and maximize drug compounding efficiency and safety
The most recent short interest data has been released for the 10/31/2016 settlement date, which shows a 296,246 share increase in total short interest for ICU Medical, Inc. , to 828,440, an increase of 55.67% since 10/14/2016.
In recent trading, shares of ICU Medical, Inc. have crossed above the average analyst 12-month target price of $142.50, changing hands for $142.80/share.
ICU Medical (ICUI) purchased Pfizer's (PFE) infusion therapy business for $1 billion,
Stocks hold mixed on Thursday afternoon as crude oil enjoys another rally and Wall Street looks toward the Friday release of the monthly jobs report.
The addition of Hospira's IV pumps, solutions, and devices business to ICU Medical's existing portfolio will create a leading pure-play infusion therapy company
Trade-Ideas LLC identified ICU Medical (ICUI) as a strong and under the radar candidate
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in ICU Medical, Inc. , where a total of 1,022 contracts have traded so far, representing approximately 102,200 underlying shares.
Fiscal Year 2015 Adjusted EBITDA Increased 54% to $114 Million
In commenting on the peer-reviewed study by clinicians at New York City's Memorial Sloan Kettering Cancer Center, an editor for the New England Journal of Medicine noted that use of these devices could "markedly outweigh the added cost" in most institutions.
Trade-Ideas LLC identified ICU Medical (ICUI) as a "perilous reversal" (up big yesterday but down big today) candidate